RE: Anyone?29 Jan 2022 14:44
Agree. They are undervalued and a secure divi. I went in quite heavy around 200. I was always advised to top up when the whole market gets nervous as opposed to weakness in the specific company/product set - so I've added at 187. My target price is north of 290 so as with GSK I will sit on it for 12 months, take the 5%+ div and see where we are end of '22. Mony seems like safe ground to me - all UK tech is under valued IMO - the silly stuff that's happened to Boo, Asos, AO, etc. looks like overdone cyclical selling. The Nas might get a bit of a slap for a few weeks, but it grew solidly for 18 months while in the UK we've spent the last 6 months pushing companies with 10-15% revenue growth down to the same PE as slow moving industrials....and below their SP pre-pandemic. Feels wrong to me but as with all cycles they will come round again, so I keep the faith.